Results 51 to 60 of about 8,668 (131)

Effectiveness of Valganciclovir 900mg Versus 450mg for Cytomegalovirus Prophylaxis in Renal Transplantation: A Systematic Review and Meta-Analysis

Journal of Pharmacy & Pharmaceutical Sciences, 2017
Objectives: Valganciclovir 900 mg/day is approved for cytomegalovirus (CMV) prophylaxis, but 450 mg/day is seems also effective. We systematically reviewed the efficacy and safety of low-dose versus high-dose valganciclovir prophylaxis in renal ...
wang xin, yang hui, zhang xiaodong, cui xiangli, wang shihui, liu lihong   +5 more
doaj   +1 more source

Hepatopulmonary Syndrome Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease in a Patient With Interstitial Pneumonia and COPD

Respirology Case Reports, Volume 14, Issue 2, February 2026.
A 57‐year‐old man with COPD and interstitial pneumonia developed profound hypoxaemia that was disproportionate to imaging findings. Further evaluation revealed very severe hepatopulmonary syndrome secondary to MASLD, complicated by drug‐induced hypersensitivity syndrome with CMV reactivation.
Shigesato Inoue, Kouta Miyamoto, Mizuko Ose, Miyoko Tatsuta, Katsuyuki Katahira, Naotaka Noda, Hiroyuki Kumazoe, Sawako Konishi, Satoru Fukuyama, Miiru Izumi, Kentaro Wakamatsu, Masayuki Kawasaki   +11 more
wiley   +1 more source

Dual Kidney Transplantation Offers Prolonged Graft Survival

Clinical Transplantation, Volume 40, Issue 2, February 2026.
ABSTRACT Introduction Dual kidney transplantation (DKT), an uncommonly performed procedure, provides a unique opportunity to transplant nonstandard kidneys that might otherwise not be utilized. We compared perioperative and five‐year posttransplant outcomes between DKT, and single kidney transplants (SKT) performed at our institution.
Ekaterina Fedorova, Sofia Nehring Firmino, David Foley, Jacqueline Garonzik‐Wang, Dixon Kaufman, Jon Odorico, David Aufhauser, Nikole A. Neidlinger, Carrie Thiessen, Jennifer Philip, Kelly M. Collins, Josh Mezrich, David Al‐Adra, Didier Mandelbrot, Brad C. Astor, Sandesh Parajuli   +15 more
wiley   +1 more source

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients

Drug Design, Development and Therapy, 2012
Andreas O Doesch,1 Janika Repp,1 Nina Hofmann,1 Christian Erbel,1 Lutz Frankenstein,1 Christian A Gleissner,1 Constanze Schmidt,1 Arjang Ruhparwar,2 Christian Zugck,1 Paul Schnitzler,3 Philipp Ehlermann,1 Thomas J Dengler,4 Hugo A Katus11Department of ...
Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA   +12 more
doaj  

Snapshot Look at Castleman Disease

Journal of Cellular and Molecular Medicine, Volume 30, Issue 3, February 2026.
ABSTRACT Castleman disease (CD) is a rare and heterogeneous group of lymphoproliferative disorders characterised by abnormal proliferation of lymphoid tissue. First described in the 1950s, it has since been classified into two major clinical forms: unicentric CD (UCD), involving a single lymph node region and multicentric CD (MCD), which affects ...
Ciprian Jitaru, Natalia Zlampa, Delia Dima, Anca Bojan, Mihnea Zdrenghea, Laura Urian, David Kegyes, Anamaria Bancos, Maria Santa, Andrei Ivancuta, Bobe Petrushev, Madalina Nistor, Bogdan Tigu, Catalin Constantinescu, Bogdan Fetica, Maria Puiu, Mihai‐Stefan Muresan, Ciprian Tomuleasa   +17 more
wiley   +1 more source

Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients

Transplant International
Valganciclovir (VGC) is administered as prophylaxis to kidney transplant recipients (KTR) CMV donor (D)+/recipient (R)− and CMV R+ after thymoglobulin-induction (R+/TG).
Nathalie Hammer, Linard Hoessly, Fadi Haidar, Cédric Hirzel, Sophie de Seigneux, Christian van Delden, Bruno Vogt, Daniel Sidler, Dionysios Neofytos   +8 more
doaj   +1 more source

Intensive Hemodiafiltration Successfully Removes Ganciclovir Overdose and Largely Exceeds Reported Elimination During Hemodialysis—A Case Report and Review of the Literature

Frontiers in Pharmacology, 2020
We present the case of a kidney transplant patient (Cockroft-Gault estimated creatinine clearance 14 ml/min) who was inadvertently eight-fold overdosed with a single dose of 500 mg intravenous ganciclovir.
Verena Gotta, Anne Leuppi-Taegtmeyer, Mirjam Gessler, Marc Pfister, Daniel Müller, Andreas Werner Jehle, Andreas Werner Jehle   +6 more
doaj   +1 more source

Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial

BMC Infectious Diseases, 2018
Background Cytomegalovirus (CMV) prophylaxis may prevent CMV indirect effects in renal transplant recipients. This study aimed to compare the efficacy of valganciclovir and valacyclovir prophylaxis for CMV after renal transplantation with the focus on ...
Tomas Reischig, Martin Kacer, Petra Hruba, Hana Hermanova, Ondrej Hes, Daniel Lysak, Stanislav Kormunda, Mirko Bouda   +7 more
doaj   +1 more source

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients

Clinical Ophthalmology, 2010
A Jayaprakash Patil1,2,3, Ashish Sharma1,4, M Cristina Kenney1, Baruch D Kuppermann11Department of Ophthalmology, Gavin S Herbert Eye Institute, University of California, Irvine, Irvine, CA, USA; 2Department of Ophthalmology, Summa Health System, Akron ...
A Jayaprakash Patil, Ashish Sharma, M Cristina Kenney, et al   +3 more
doaj  

Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?

Advances in Virology, 2011
The resistance of cytomegalovirus (CMV) to ganciclovir or valganciclovir is a factor in therapeutic failure and disease progression. CMV strains resistant to ganciclovir or valganciclovir have been associated with specific mutations in the UL97 and UL54 ...
Nada Madi, Widad Al-Nakib, Alexander Pacsa   +2 more
doaj   +1 more source